Skip to main content

DocGo Inc.

corporate_fare Company Profile

DocGo Inc.

DCGO·NASDAQ·Healthcare·CIK 0001822359

DocGo provides mobile health services, virtual care management, and ambulance services through its care delivery platform. The company operates in all 50 states and the United Kingdom, utilizing a proprietary technology platform, a network of certified health professionals including virtual care clinicians, and a fleet of medical response vehicles. DocGo's services are provided to municipalities, hospital networks, and health insurance providers, often through long-term relationships with leading healthcare organizations. In 2025, DocGo expanded its capabilities by acquiring a 50-state virtual care network that offers white-label telehealth services to consumer, healthcare, and digital wellness brands, including multiple Fortune 10 customers. The company also acquired a mobile phlebotomy provider in the northeast. DocGo's clinicians traveled over 11 million miles to facilitate care across more than 1.3 million patient interactions. Since 2015, the company's care delivery model has facilitated over 10 million patient interactions. DocGo's platform is designed to manage patient transportation and mobile health services.

DocGo Inc. (NASDAQ:DCGO) is a publicly traded company in the Healthcare sector. Wiseek monitors DCGO SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • DocGo Reports Wider Q1 Loss, Revenue Decline, Faces Nasdaq Delisting & Going Concern Doubts
  • DocGo Boosts 2026 Revenue Outlook, Core Business Up 19% After Q1 Beat
  • DocGo Raises 2026 Revenue Guidance Amid Strong Virtual Care Demand, Reports Mixed Q1 Results
  • DocGo Finalizes Proxy for Shareholder Vote on Reverse Split, Governance Changes Amid Going Concern Warning
  • DocGo Forms Special Committee for Profitability, Appoints New Independent Board Chair

monitoring Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$322.2M
Net Income
-$182.4M
Diluted EPS
-$1.84
Op. Cash Flow
$34.45M
Free Cash Flow
$29.91M
Operating Income
-$178.03M
Cash & Equivalents
$51.02M
Debt / Equity
0.00×
Net Margin
-56.6%
Shares Outstanding
98.64M sh
Source: 10-K · filed 2026-03-16 · accession 0001628280-26-018214

supervised_user_circle Insider Transactions

$13.3K bought $15.33K sold
Net $2.03K selling · 2 transactions by 2 insiders · last 12 months
  • 2025-05-23 Burdiek Michael J Director
    Open-market purchase 10K sh $13.3K @ $1.33
  • 2025-12-15 Tendler Ely D General Counsel and Secretary Officer · Director
    Open-market sale 16.85K sh $15.33K @ $0.91
  • 2026-05-12 Bienstock Lee Chief Executive Officer Officer · Director
    Tax/exercise cost 15.64K sh $9.23K @ $0.59
  • 2026-03-30 Bienstock Lee Chief Executive Officer Officer · Director
    Tax/exercise cost 18.81K sh $10.72K @ $0.57
  • 2025-12-15 ROSENBERG NORMAN CFO and Treasurer Officer
    Tax/exercise cost 65.77K sh $59.85K @ $0.91
  • 2025-12-15 Sugrue Stephen Chief Compliance Officer Officer
    Tax/exercise cost 35.97K sh $32.73K @ $0.91
  • 2025-12-15 Bienstock Lee Chief Executive Officer Officer · Director
    Tax/exercise cost 214.13K sh $194.86K @ $0.91
  • 2025-12-12 TRAVERS JAMES M Director
    Grant/Award 150K sh
  • 2025-12-12 Burdiek Michael J Director
    Grant/Award 150K sh
  • 2025-12-12 Tendler Ely D General Counsel and Secretary Officer · Director
    Grant/Award 100K sh
  • 2025-12-12 ROSENBERG NORMAN CFO and Treasurer Officer
    Grant/Award 429.4K sh
  • 2025-12-12 Leite Etalvina Director
    Grant/Award 150K sh
  • 2025-12-12 Smedra Ira Director
    Grant/Award 150K sh
  • 2025-12-12 Sugrue Stephen Chief Compliance Officer Officer
    Grant/Award 321.06K sh
  • 2025-12-12 Bienstock Lee Chief Executive Officer Officer · Director
    Grant/Award 1.11M sh
  • 2025-09-10 Klasko Stephen K. M.D. Director
    Grant/Award 100K sh
  • 2025-07-02 ROSENBERG NORMAN CFO and Treasurer Officer
    Tax/exercise cost 11.33K sh $17.22K @ $1.52
  • 2025-07-02 Sugrue Stephen Chief Compliance Officer Officer
    Tax/exercise cost 5.81K sh $8.84K @ $1.52
  • 2025-07-02 Bienstock Lee Chief Executive Officer Officer · Director
    Tax/exercise cost 18.6K sh $28.27K @ $1.52
From SEC Form 4 + 5 (insider beneficial-ownership filings) · last 12 months · view all on SEC EDGAR ↑
$0.6 -0.00% today
52-week range $0.49 – $1.93
Market cap
$59.43M
Volume
544.6K (0.7× avg)
3-mo avg 830.7K
Price snapshot as of 2026-05-22 01:52 UTC (Market snapshot (OVERNIGHT))

show_chartPrice Chart

Loading chart...

feed DCGO - Latest Insights

DCGO
May 11, 2026, 4:32 PM EDT
Filing Type: 10-Q
Importance Score:
9
DCGO
May 11, 2026, 4:23 PM EDT
Source: Reuters
Importance Score:
8
DCGO
May 11, 2026, 4:09 PM EDT
Filing Type: 8-K
Importance Score:
8
DCGO
Apr 22, 2026, 4:06 PM EDT
Filing Type: DEF 14A
Importance Score:
9
DCGO
Apr 21, 2026, 9:32 PM EDT
Filing Type: 8-K
Importance Score:
7
DCGO
Apr 10, 2026, 4:05 PM EDT
Filing Type: PRE 14A
Importance Score:
9
DCGO
Mar 16, 2026, 4:30 PM EDT
Filing Type: 10-K
Importance Score:
9
DCGO
Mar 16, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
9
DCGO
Feb 26, 2026, 4:13 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
DCGO
Jan 30, 2026, 5:12 PM EST
Filing Type: 8-K
Importance Score:
9